University of Bradford

Parker Health Announces the Appointment of Dr. Tushar Hazra as Chief Technology Officer, and Other Key Executive Personnel

Retrieved on: 
Wednesday, December 6, 2023
Software, Other Health, Professional Services, Telemedicine, Virtual Medicine, Data Management, Biometrics, Technology, Artificial Intelligence, Health Technology, Data Analytics, Biotechnology, Practice Management, Health, Nursing, Johns Hopkins, BIP, Mental health, Federally Qualified Health Center, MetLife, Herbert Parker (health physicist), Doctor of Philosophy, Safety, NYS, Lockheed Martin, Holy Cross Hospital, Roger Hawkins (drummer), Military Health System, FQHC, Public, Campbell University, Artificial intelligence, Health information management, Application development, IPO, University, Control, George Washington University, Lockheed, Oakwood University, Kaiser Permanente, Social services, Health communication, Control engineering, University of Bradford, Computer science, NIH, Digital technology, Critical care, Management, Science, Southern Adventist University, Public health, Engineering

Parker Health, Inc, a prominent biotech company, is delighted to introduce Dr. Tushar Hazra as its new Chief Technology Officer (CTO), leveraging his extensive expertise in digital technology within healthcare informatics, electronic health records, artificial intelligence, and data governance.

Key Points: 
  • Parker Health, Inc, a prominent biotech company, is delighted to introduce Dr. Tushar Hazra as its new Chief Technology Officer (CTO), leveraging his extensive expertise in digital technology within healthcare informatics, electronic health records, artificial intelligence, and data governance.
  • Dr. Hazra joins Parker Health with an impressive background of 20+ years of expertise leading $500M+ dollars in digital transformation initiatives.
  • Additionally, we are pleased to welcome Michael Forde, Director of Public Health Innovation, and Clayton Tuckett, Director of Clinical Care Innovation.
  • "We are thrilled to welcome Dr. Hazra, Mr. Forde, and Mr. Tuckett to the Parker Health family.

Aker Carbon Capture appoints Julie Berg as Chief Financial Officer

Retrieved on: 
Friday, October 6, 2023
Carbon, Assurance, Audit, Risk, University, Initial public offering, Foreign language, Growth, University of Bradford, Economics, ASA, KPMG, CFO, Risk assessment, Management, Atlantic Ocean

OSLO, Norway, Oct. 6, 2023 /PRNewswire/ -- Aker Carbon Capture ASA announces the appointment of Julie Berg as Chief Financial Officer, effective December 1, 2023.

Key Points: 
  • OSLO, Norway, Oct. 6, 2023 /PRNewswire/ -- Aker Carbon Capture ASA announces the appointment of Julie Berg as Chief Financial Officer, effective December 1, 2023.
  • "We are excited to welcome Julie to Aker Carbon Capture.
  • I am confident that she can apply her skillset to enhancing the efficiency of our operating model as we expand into new markets and industries," says Egil Fagerland, Chief Executive Officer of Aker Carbon Capture.
  • "I am thrilled about the opportunity to serve as CFO at this exciting time for Aker Carbon Capture.

Aker Carbon Capture appoints Julie Berg as Chief Financial Officer

Retrieved on: 
Friday, October 6, 2023
Carbon, Assurance, Audit, Risk, University, Initial public offering, Foreign language, Growth, University of Bradford, Economics, ASA, KPMG, CFO, Risk assessment, Management, Atlantic Ocean

OSLO, Norway, Oct. 6, 2023 /PRNewswire/ -- Aker Carbon Capture ASA announces the appointment of Julie Berg as Chief Financial Officer, effective December 1, 2023.

Key Points: 
  • OSLO, Norway, Oct. 6, 2023 /PRNewswire/ -- Aker Carbon Capture ASA announces the appointment of Julie Berg as Chief Financial Officer, effective December 1, 2023.
  • "We are excited to welcome Julie to Aker Carbon Capture.
  • I am confident that she can apply her skillset to enhancing the efficiency of our operating model as we expand into new markets and industries," says Egil Fagerland, Chief Executive Officer of Aker Carbon Capture.
  • "I am thrilled about the opportunity to serve as CFO at this exciting time for Aker Carbon Capture.

Ailie MacAdam elected to Bechtel Group Inc. Board of Directors

Retrieved on: 
Thursday, December 1, 2022
American Institute of Chemical Engineers, Copper, Engineering, University of Bradford, Chemical engineering, Government, M&M, Security, Workforce, Mining, Ailie MacAdam, Manufacturing Technologies Association, Woman, Lithium, Biophysical environment, Built environment, Management, Renewable energy, Energy, Metal, Infrastructure

RESTON, Va., Dec. 1, 2022 /PRNewswire/ -- Bechtel announced today that Ailie MacAdam , president of Bechtel's Mining and Metals business, has been elected to the Bechtel Group Inc. Board of Directors.

Key Points: 
  • RESTON, Va., Dec. 1, 2022 /PRNewswire/ -- Bechtel announced today that Ailie MacAdam , president of Bechtel's Mining and Metals business, has been elected to the Bechtel Group Inc. Board of Directors.
  • Ailie has been with the company 37 years, serving in leadership and operational roles across industries and geographies.
  • "I look forward to contributing to the Board and working to build on Bechtel's long track record of leadership and success."
  • Since 2020, Ailie has been serving as the president of Bechtel's Mining and Metals (M&M) business, with responsibility for all aspects of M&M's worldwide portfolio.

GSA Further Strengthens European Representation

Retrieved on: 
Tuesday, October 11, 2022
Software, Internet, Hardware, Engineering, Consumer Electronics, Technology, Semiconductor, Manufacturing, LinkedIn, STMicroelectronics, General manager, TheCityUK, Courage, Instagram, Sole, Council, SRA, University, CEO, Innovation, Ben-Gurion University of the Negev, Board of directors, BSC, WeChat, Solution, VLSI, Semiconductor, IOT, Eindhoven University of Technology, Technology, GSA, University of Bradford, DSP Group, YouTube, DSP, Global, Engineering, MBA, Twitter, Executive, Software, Industry, Shelton, CMO, SIP, Infineon Technologies, Female, EMEA, Electronic engineering, ST, Research, Management science, Cremonesi, Goal, Board, Ecosystem, CEVA, Chery, View, Marketing, Executive Committee, IFX, United Kingdom, Silicon, Management, Science, Director, Facebook, Electronics

To further strengthen its representation in the Europe, Middle East and Africa (EMEA) region, the Global Semiconductor Alliance (GSA) announces new European members on its Board of Directors and on its EMEA Leadership Council .

Key Points: 
  • To further strengthen its representation in the Europe, Middle East and Africa (EMEA) region, the Global Semiconductor Alliance (GSA) announces new European members on its Board of Directors and on its EMEA Leadership Council .
  • I am extremely pleased to have both Andreas and Jean-Marc join the GSA Board of Directors, said Jodi Shelton, CEO of GSA .
  • In addition to its new board members, GSA also announces three new members to its EMEA Leadership Council.
  • Members of the GSA represent 70 percent of the $500B+ semiconductor industry and continue to grow.

Recce Pharmaceuticals Appoints Philip Sutton, Ph.D., as Vice President of Translational Sciences

Retrieved on: 
Tuesday, July 12, 2022
RCE, Inflammation, Safety, Clinical and Translational Science, FSE, Gram-negative bacteria, Infection, GAIN, Company, Synthetic, Biomedical sciences, Recce, Program, Philip Sutton, Bacteria, CSL Limited, ASX, Degenerative disease, GLOBE, Murdoch, University of Manchester, Virus, Doctor of Philosophy, Human, Textbook, Pew, FDA, Research, Head, University of Bradford, Industry, Helicobacter pylori, Pharmaceutical industry, Vaccine, Immunology

SYDNEY Australia, July 12, 2022 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q) (the Company), the company developing a new class of synthetic anti-infectives, is pleased to announce the appointment of Philip Sutton, Ph.D., as Vice President of Translational Sciences.

Key Points: 
  • SYDNEY Australia, July 12, 2022 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q) (the Company), the company developing a new class of synthetic anti-infectives, is pleased to announce the appointment of Philip Sutton, Ph.D., as Vice President of Translational Sciences.
  • Dr. Sutton joins us at an exciting time as our clinical programs continue to advance, said James Graham, Chief Executive Officer of Recce Pharmaceuticals.
  • He was Chief Editor of a textbook titled Helicobacter pylori in the 21st Century and has co-authored 99 peer-reviewed publications.
  • RECCE 327 is not yet market approved for use in humans with further clinical testing required to fully evaluate safety and efficacy.

Secoo Announces Changes to Board Composition

Retrieved on: 
Tuesday, April 19, 2022
Board, Annual report, University of Nottingham, U.S. Securities and Exchange Commission, MBA, NASDAQ, Warburg Pincus, Private Securities Litigation Reform Act, Board of directors, GLOBE, Public Interest Declassification Board, Securities Act of 1933, Terminology, Honeywell, Coal, Securities Exchange Act of 1934, Growth, Stock, Company, Asia-Pacific Economic Cooperation, National Semiconductor, University of Bradford, SECO, App Store (iOS/iPadOS), Management, Amphenol, Secoo

BEIJING, April 19, 2022 (GLOBE NEWSWIRE) -- Secoo Holding Limited (Secoo or the Company) (NASDAQ: SECO), Asias leading online integrated upscale products and services platform, today announced that its Board of Directors (the Board) has approved the appointment of Mr.

Key Points: 
  • BEIJING, April 19, 2022 (GLOBE NEWSWIRE) -- Secoo Holding Limited (Secoo or the Company) (NASDAQ: SECO), Asias leading online integrated upscale products and services platform, today announced that its Board of Directors (the Board) has approved the appointment of Mr.
  • Shun Lam Tang as a director to the Board and the resignation of Dr. Jun Wang from the Board, both effective April 19, 2022.
  • Were pleased and honored to welcome Mr. Tang to our Board, said Mr. Richard Rixue Li, Chairman and Chief Executive Officer of Secoo.
  • On behalf of the Board, I would also thank Dr. Wang for his contributions to Secoo during his tenure and wish him the best in his future endeavors.

Adhera Therapeutics Announces Appointment of Dr. Zahed Subhan to Board of Directors

Retrieved on: 
Monday, November 8, 2021
Aston, Neurology, Therapy, Type, Russell, Acquisition, Urology, Solution, Rouge, Business development, Board of directors, University of Leeds, University of West London, School, Bristol Myers Squibb, DuPont (1802–2017), Neuroscience, European, Russell Group, MBA, LLB, Pharmacology, USA, Biotechnology, NASH, GLOBE, Psychopharmacology, FDA, BS, Amgen, Psychology, Psychiatry, CEO, University of Bradford, Lists of diseases, Research university, Sale, Marketing, Drug discovery, Clinical research, ATRX, University, Drexel University, EMA, Aston University, Board, Sanofi, Drug development, Pharmaceutical industry, Fine chemical, Medicine

Baton Rouge, LA, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Adhera Therapeutics, Inc. (OTCPK: ATRX) ("Adhera" or the "Company"), a clinical stage biopharmaceutical company, is pleased to announce the appointment of Zahed Subhan, BS MS PhD MBA LLB, to the Companys Board of Directors.

Key Points: 
  • Baton Rouge, LA, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Adhera Therapeutics, Inc. (OTCPK: ATRX) ("Adhera" or the "Company"), a clinical stage biopharmaceutical company, is pleased to announce the appointment of Zahed Subhan, BS MS PhD MBA LLB, to the Companys Board of Directors.
  • Dr. Subhan is an international pharmaceutical and biotechnology executive with more than 30 years experience in the United States, United Kingdom, European Union, and Asia.
  • He is highly proficient in all phases of drug development with expertise in neurology, psychiatry, oncology, cardiovascular, urology and metabolic disease therapeutic areas.
  • Dr. Subhan has authored 40+ peer-reviewed papers published in academic journals on the topics of clinical pharmacology and business.

Four Members Elected to the ATA Board of Directors to Help Advance Tinnitus Research and Management

Retrieved on: 
Wednesday, October 20, 2021
Veteran, Head, Research, Quality of life, University, Association, College, Benedictine College, CA, Salus University, Communication, MBA, Tinnitus, Hearing loss, Patient, Marketing, University of Bradford, Language, MS, Deafness, Effectiveness, Time, American Tinnitus Association, Brain, ATA, Strategic planning, National, National Institutes of Health, Hartnell College, Doctor of Audiology, University of California, San Francisco, Royal National Institute for Deaf People, Champaign County, Illinois, Computation and Neural Systems, National Institute, Cognitive hearing science, Doctor of Philosophy, Tobacco Products Scientific Advisory Committee, Department, University of Colorado Denver School of Public Affairs, Boston University, Physician, Idaho State University, Dentistry, Management

VIENNA, Va., Oct. 20, 2021 /PRNewswire-PRWeb/ -- The American Tinnitus Association elected four members to its board of directors to further advance its mission to improve evidence-based tinnitus treatments, educate healthcare providers on tinnitus management, and research potential cures.

Key Points: 
  • VIENNA, Va., Oct. 20, 2021 /PRNewswire-PRWeb/ -- The American Tinnitus Association elected four members to its board of directors to further advance its mission to improve evidence-based tinnitus treatments, educate healthcare providers on tinnitus management, and research potential cures.
  • The ATA Board of Directors guides the organization in its efforts to provide guidance on tinnitus management, educate physicians and other healthcare providers on evidence-based tinnitus treatments and management tools, and fund international research initiatives aimed at curing and treating tinnitus.
  • Newly Elected ATA Board Members:
    Sara K. Downs, AuD, is the owner of Hearing Wellness Center and Tinnitus Treatment Center in Duluth, MN.
  • Call the ATA at 1-800-634-8978, if you need general guidance on tinnitus management and finding qualified healthcare providers for care.

Leading UK Universities Choose Handshake to Boost Social Mobility

Retrieved on: 
Tuesday, September 28, 2021
News, Kingston University, Career, Birkbeck, University of London, University, Workforce, Student, University of Central Lancashire, Aptitude, Brunel University London, Social mobility, University of Bradford, Life, General manager, Associate, Technology, Cognitive Information Processing (Career Services), EMEA, Central Lancashire, College, Tutoring, Management

As more universities turn away from legacy tools, these new partnerships will see Handshake add more than 75,000 students to its user base in the UK.

Key Points: 
  • As more universities turn away from legacy tools, these new partnerships will see Handshake add more than 75,000 students to its user base in the UK.
  • This means universities like Birkbeck, Kingston, UCLan and Bradford which recently topped a new university league table for England based on its impact on improving students' social mobility can unlock access to the broadest range of employment opportunities.
  • Dimitar Stanimiroff, General Manager EMEA at Handshake said: "We're delighted to add these trailblazing institutions to the growing roster of UK universities which are harnessing Handshake's platform.
  • Unlike other networks, Handshake doesn't just offer a communications platform, but a dynamic way for students and employers to engage throughout their studies ultimately leading to better skilled, better qualified, graduate recruits."